4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006318
CHIEF FINANCIAL OFFICER sold 2,806 shares at $2.35 ($6,594)
- CHIEF FINANCIAL OFFICER acquired 6,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2025-03-01 | Option exercise | +6,750 | 26,750 | D | ||
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2025-03-03 | Sale | −2,806 | $2.35 | $6,594 | 23,944 | D |
| Derivatives | |||||||
| Giacobello Scott M. CHIEF FINANCIAL OFFICER | 2025-03-01 | Option exercise · Restricted Stock Units | −6,750 | 20,250 | D | ||
| Open-market sales · 2,806 sh · avg $2.35 · $6,594 | |||||||
Loading xslF345X05/form4-03042025_010336.xml…